These findings, together with the above demonstrate that regardless of stratification by molecular classification or WHO grade, both CDKN2A mRNA expression and the incidence of CDKN2A homodel is consistently increased in more biologically aggressive meningiomas. This evidence concerns the gene CDKN2A and meningioma.